Position in PGEN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,209,947
+$760,578 QoQ
Shares Held
387,710
+3.5% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 210 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $188,506,278 across 113 Biotechnology names. PGEN ranks #22 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,196 | $6,982,691 |
All Filings in PGEN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,209,947 | 387,710 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,449,369 | 374,514 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,551,883 | 371,264 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,239,412 | 376,721 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $382,636 | 269,462 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $423,252 | 284,062 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $317,589 | 283,562 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $247,296 | 260,312 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $423,142 | 267,812 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $377,742 | 260,512 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $337,110 | 251,575 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $341,971 | 240,825 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $272,348 | 236,825 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $247,324 | 233,325 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $246,582 | 162,225 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $340,843 | 160,775 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $214,366 | 159,975 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $315,841 | 149,688 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $443,819 | 119,628 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $241,535 | 48,404 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||